| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.092 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |